SBH
TWST icon

Segall Bryant & Hamill’s Twist Bioscience TWST Stock Holding History

Segall Bryant & Hamill’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,865
Closed -$6.06M – 828
2020
Q4 		$6.06M Sell
42,865
-22,410
-34% -$2.49M 0.07% 261
2020
Q3 		$4.96M Buy
65,275
+47,380
+265% +$2.95M 0.07% 264
2020
Q2 		$811K Buy
+17,895
New +$642K 0.01% 479

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Segall Bryant & Hamill's TWST Position: Q1 2021 in Review

Segall Bryant & Hamill sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 42,865 shares — an estimated $6.06M sold.

Segall Bryant & Hamill first reported a position in TWST in Q2 2020 and held it in 3 quarters. The position peaked at $6.06M in Q4 2020. 239 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

  • Segall Bryant & Hamill reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
  • Segall Bryant & Hamill sold 42,865 Twist Bioscience shares in Q1 2021, an estimated $6.06M.
  • Segall Bryant & Hamill first reported a position in Twist Bioscience in Q2 2020 and held it in 3 quarters.
  • Segall Bryant & Hamill's Twist Bioscience position peaked at $6.06M in Q4 2020.
  • 239 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Segall Bryant & Hamill's 13F filing for Q1 2021, filed 13 May 2021.